Connexion
E-mail
Mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

Accueil Zonebourse  >  Actions  >  Euronext Paris  >  NicOx SA    NCOX   FR0000074130

NICOX SA (NCOX)

Mes dernières consult.
Top consultations
1721
SynthèseGraphiquesActualitésAnalysesAgendaSociétéFinancesConsensusRévisionsFondsCommunauté 
Métier
Logo NicOx SA
Developes and manufactures biopharmaceuticals

Nicox SA is an international commercial-stage company focused on the ophthalmic market.

It seeks and evaluate commercial and late-stage ophthalmic products.

The company was founded by Piero Del Soldato, Michele Garufi and Elizabeth Marie Robinson on February 15, 1996 and is headquartered in Sophia-Antipolis, France.
Dirigeants
Nom AgeDepuisTitre
Michele Garufi621996Chairman & Chief Executive Officer
Sandrine Gestin491999Finance Director
Michael Bergamini, PhD-2014Chief Scientific Officer & Executive VP
Jean-François Labbé, MBA662010Director
Birgit Stattin Norinder692011Director
Adrienne L. Graves, PhD632014Director
Luzi Andreas von Bidder642014Director
Lester J. Kaplan, PhD662014Director
Gavin M. Spencer, PhD462005Executive Vice President-Corporate Development
Staffan Strömberg, PhD--Vice President
Actions
Vote NombreFlottantAutocontrôleFlottant Total
Action A 1 22 949 913 22 643 897 98.7% 50 903 0.2% 98.7%
Actionnaires
Nom Actions%
Bpifrance Participations SA /PRIVATE EQUITY/ 790 514 3,16%
HBM Partners AG 750 000 2,99%
New Enterprise Associates LLC 283 094 1,13%
Highland Capital Management LP 208 535 0,83%
Michele Garufi 181 051 0,72%
Dimensional Fund Advisors LP 139 262 0,56%
OP Asset Management Ltd. 80 000 0,32%
Elizabeth Marie Robinson, PhD 74 060 0,30%
Lester J. Kaplan, PhD 69 131 0,28%
Nicox SA 50 903 0,20%
Participations
Nom Actions%Valorisation
Nicox (COX) 50 9030,20%475 988 USD
Secteur
Santé
Recherche pharmaceutique et médicale
 Produits pharmaceutiques
  Produits pharmaceutiques
   Pharmacies spécialisées et de pointe
Publicité
Secteur Pharmacies spécialisées et de pointe
Var. 1janvCapitalisation (M$)
NICOX SA-22.33%254
ABBVIE INC5.37%105 144
MERCK KGAA4.69%14 506
KYOWA HAKKO KIRIN CO L..8.78%9 127
JAZZ PHARMACEUTICALS P..33.83%8 717
CONVATEC GROUP PLC14.96%6 587
MALLINCKRODT PLC-11.02%4 641
ZHANGZHOU PIENTZEHUANG..9.22%4 358
BETTA PHARMACEUTICALS ..--.--%4 169
INDIVIOR PLC7.36%2 866
YUHAN CORP--.--%2 355
ADVANCED ACCELERATOR A..--.--%1 687
MAYNE PHARMA GROUP LTD3.35%1 599
SUPERNUS PHARMACEUTICA..22.18%1 548
THERAPEUTICSMD INC17.85%1 381
EAGLE PHARMACEUTICALS ..3.16%1 246
REPLIGEN CORPORATION12.75%1 176
AIMMUNE THERAPEUTICS I..9.19%1 122
KNIGHT THERAPEUTICS IN..-4.30%1 091
FUJIAN COSUNTER PHARMA..--.--%1 055
NICHI-IKO PHARMACEUTIC..3.89%948
Secteur Pharmacies spécialisées et de pointe
NicOx SA : Connexions
Medinox, Inc.
Pan-American Ophthalmological Foundation
American Academy of Ophthalmology, Inc.
Aciex Therapeutics, Inc.
Delife SRL
Wingfirm Pharma AB
Envisia Therapeutics, Inc.
Partners för Utvecklingsinvesteringar inom Life Sciences AB
Navigation Dynamics AB
FFB Clinical Research Institute
Wntresearch AB
KeepYourSight Foundation
Women in Ophthalmology
Himalayan Cataract Project
The Association for Research in Vision & Ophthalmology
Relivia SRL
American Glaucoma Society
Ferring International Center SA
Neurotech Pharmaceuticals, Inc. (United States)
American Academy of Ophthalmology Foundation
Ferring Holding SA
The American Society of Cataract & Refractive Surgery
The Clinical Research Institute of the Foundation
Glaucoma Research Foundation
Keck Graduate Institute of Applied Life Sciences
Aerpio Therapeutics, Inc.
Infant Bacterial Therapeutics AB
Coordonnées société
Nicox SA
Drakkar 2 - Bât D
2405 route des Dolines
Sophia-Antipolis, Provence-Alpes-Cote-dAzur 06560

Phone : +33.4.97.24.53.00
Fax : +33.4.97.24.53.99
Web : www.nicox.com
© 2017 People , Fundamentals and Ownership